Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 2:02 pm Sale | 2024-12-31 | 13G | U.S.PHYSICAL THERAPY INC USPH | Morgan Stanley MS | 889,644 5.900% | -149,773 (-14.41%) | Filing History |
| 2025-02-05 1:51 pm Sale | 2024-12-31 | 13G | SPHERE ENTERTAINMENT CO. SPHR | Morgan Stanley MS | 1,270,866 4.400% | -782,116 (-38.10%) | Filing History |
| 2025-02-05 1:44 pm Sale | 2024-12-31 | 13G | COHEN STEERS REAL ESTATE OPPOR RLTY | Morgan Stanley MS | 679,684 4.100% | -308,903 (-31.25%) | Filing History |
| 2025-02-05 1:06 pm Sale | 2024-12-31 | 13G | WESTERN ASSET INFLATION-LINKED WIW | Morgan Stanley MS | 2,487,171 4.100% | -2,053,853 (-45.23%) | Filing History |
| 2025-02-05 10:46 am Purchase | 2024-12-31 | 13G | WESTERN ASSET INFLATION-LINKED WIW | Morgan Stanley MS | 4,541,024 7.400% | 182,866 (+4.20%) | Filing History |
| 2025-02-05 10:43 am Purchase | 2024-12-31 | 13G | TAYSHA GENE THERAPIES INC TSHA | Morgan Stanley MS | 17,629,264 8.600% | 17,629,264 (New Position) | Filing History |
| 2025-02-05 10:41 am Purchase | 2024-12-31 | 13G | SAGE THERAPEUTICS INC SAGE | Morgan Stanley MS | 4,542,992 7.400% | 4,542,992 (New Position) | Filing History |
| 2025-02-05 10:38 am Sale | 2024-12-31 | 13G | BROOKFIELD REAL ASSETS INCOME RA | Morgan Stanley MS | 2,455,074 4.400% | -1,268,631 (-34.07%) | Filing History |
| 2025-02-05 10:23 am Purchase | 2024-12-31 | 13G | WESTERN ASSET PREMIER BOND FD WEA | Morgan Stanley MS | 1,538,313 13.000% | 133,391 (+9.49%) | Filing History |
| 2025-02-05 10:10 am Purchase | 2024-12-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Morgan Stanley MS | 1,157,140 6.200% | 1,157,140 (New Position) | Filing History |
| 2025-02-05 10:09 am Sale | 2024-12-31 | 13G | UROGEN PHARMA LTD URGN | Morgan Stanley MS | 752,861 1.800% | -1,419,466 (-65.34%) | Filing History |
| 2025-02-05 10:07 am Purchase | 2024-12-31 | 13G | GALAXY NEXT GENERATION INC GAXYQ | Morgan Stanley MS | 4,836,001 6.900% | 4,836,001 (New Position) | Filing History |
| 2025-02-05 10:05 am Purchase | 2024-12-31 | 13G | TORTOISE ENERGY INFRASTRUCTURE TYG | Morgan Stanley MS | 960,816 8.900% | 205,924 (+27.28%) | Filing History |
| 2025-02-05 10:03 am Purchase | 2024-12-31 | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Morgan Stanley MS | 5,362,169 6.300% | 5,362,169 (New Position) | Filing History |
| 2025-02-05 10:01 am Purchase | 2024-12-31 | 13G | ATRENEW INC SPONSORED ADS RERE | Morgan Stanley MS | 4,890,678 5.600% | 4,890,678 (New Position) | Filing History |
| 2025-02-05 09:58 am Sale | 2024-12-31 | 13G | RCM TECHNOLOGIES INC RCMT | Morgan Stanley MS | 226,984 3.000% | -174,584 (-43.48%) | Filing History |
| 2025-02-04 2:28 pm Purchase | 2024-12-31 | 13G | RIVERNORTH/DOUBLELINE STRATEGI OPP | Morgan Stanley MS | 1,998,931 8.700% | 1,670,967 (+509.50%) | Filing History |
| 2025-02-04 2:23 pm Sale | 2024-12-31 | 13G | NUVEEN VAR RATE PFD & INCOME F NPFD | Morgan Stanley MS | 594,330 2.500% | -615,883 (-50.89%) | Filing History |
| 2025-02-04 2:13 pm Purchase | 2024-12-31 | 13G | MARINUS PHARMACEUTICALS INC MRNS | Morgan Stanley MS | 3,298,215 6.000% | 3,298,215 (New Position) | Filing History |
| 2025-02-04 2:08 pm Sale | 2024-12-31 | 13G | KEY TRONIC CORP KTCC | Morgan Stanley MS | 1,726,280 16.000% | -150,360 (-8.01%) | Filing History |